SEC Form 4 · accession 0001104659-15-023581
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason B. Shandell
Officer — President · Director
Period of report
Jul 7, 2014
Accepted (ET)
Mar 30, 2015 · 6:02 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 7, 2014 | F | 4,413 | $8.75 | D | 123,019 | D | |
| Common StockF1 | Aug 1, 2014 | F | 1,352 | $8.84 | D | 121,667 | D | |
| Common StockF1 | Sep 26, 2014 | F | 770 | $11.83 | D | 120,897 | D | |
| Common StockF1 | Oct 3, 2014 | F | 988 | $11.41 | D | 119,909 | D | |
| Common StockF2 | Mar 26, 2015 | A | 50,167 | $0.00 | A | 170,076 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $14.95 | Mar 26, 2015 | A | 150,183 | A | — | Mar 26, 2025 | Common Stock | 150,183 | 150,183 | D |
Explanation of responses
- F1The reported securities were withheld to satisfy the Reporting Person's tax liability in connection with the vesting of deferred stock units (DSUs).
- F2The reported securities are represented by DSUs which vest in four equal annual installments beginning on March 26, 2016.
- F3Shares subject to the option vest in four equal annual installments beginning on March 26, 2016.